IBRXImmunityBio, Inc.Mar 3, 2026Q4 2025
Read transcript →ImmunityBio, Inc. (IBRX) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$6.46
-25.94%
Mkt Cap $9.15B
IBRXImmunityBio, Inc.Mar 3, 2026IBRXImmunityBio, Inc.Mar 3, 2026NASDAQ·Healthcare·Biotechnology
$6.46
-25.94%
Mkt Cap $9.15B
IBRXImmunityBio, Inc.Mar 3, 2026Q4 2025
Read transcript →